Aurisco Pharmaceutical Co.,Ltd. — Investor Relations & Filings
About Aurisco Pharmaceutical Co.,Ltd.
Aurisco Pharmaceutical Co.,Ltd. specializes in the development and large-scale manufacturing of complex Active Pharmaceutical Ingredients (APIs) and intermediates. The company maintains a specialized portfolio focusing on steroids, hormones, prostaglandins, and high-potency compounds, while expanding into oligonucleotides and peptides. It provides integrated Contract Development and Manufacturing Organization (CDMO) services, supporting global partners from process development to commercial-scale production. Aurisco operates advanced manufacturing sites compliant with international regulatory standards, including those of the FDA and EMA. Its technical capabilities include sophisticated chemical synthesis, fermentation, and purification technologies, designed to meet the requirements of global healthcare innovators.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 奥锐特药业股份有限公司关于通过高新技术企业认定的公告 | 2026-03-20 | Chinese | |
| 奥锐特药业股份有限公司关于持股5%以上股东权益变动触及1%刻度的提示性公告 | 2026-03-17 | Chinese | |
| 公告2026-006：奥锐特药业股份有限公司关于公司获得药品注册批件的公告 | 2026-03-16 | Chinese | |
| 奥锐特药业股份有限公司关于部分董事减持股份计划公告 | 2026-01-30 | Chinese | |
| 奥锐特药业股份有限公司关于股份回购实施结果暨股份变动的公告 | 2026-01-21 | Chinese | |
| 奥锐特药业股份有限公司关于调整回购价格上限的公告 | 2026-01-12 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
8 filings
| |||||
| 39179776 | 奥锐特药业股份有限公司关于通过高新技术企业认定的公告 | 2026-03-20 | Chinese | ||
| 39179767 | 奥锐特药业股份有限公司关于持股5%以上股东权益变动触及1%刻度的提示性公告 | 2026-03-17 | Chinese | ||
| 39179759 | 公告2026-006：奥锐特药业股份有限公司关于公司获得药品注册批件的公告 | 2026-03-16 | Chinese | ||
| 39179758 | 奥锐特药业股份有限公司关于部分董事减持股份计划公告 | 2026-01-30 | Chinese | ||
| 39179748 | 奥锐特药业股份有限公司关于股份回购实施结果暨股份变动的公告 | 2026-01-21 | Chinese | ||
| 39179741 | 奥锐特药业股份有限公司关于调整回购价格上限的公告 | 2026-01-12 | Chinese | ||
| 39179734 | 奥锐特药业股份有限公司关于可转债转股结果暨股份变动公告 | 2026-01-05 | Chinese | ||
| 39179729 | 奥锐特药业股份有限公司关于以集中竞价交易方式回购公司股份的进展公告 | 2026-01-04 | Chinese | ||
|
2025
7 filings
| |||||
| 39179719 | 国泰海通证券股份有限公司关于奥锐特药业股份有限公司向不特定对象发行可转换公司债券第三次临时受托管理事务报告 | 2025-12-30 | Chinese | ||
| 39179703 | 国浩律师（杭州）事务所关于奥锐特药业股份有限公司2022年限制性股票激励计划部分限制性股票回购注销实施的法律意见书 | 2025-12-30 | Chinese | ||
| 39179690 | 奥锐特药业股份有限公司关于部分限制性股票回购注销不调整“奥锐转债”转股价格的公告 | 2025-12-30 | Chinese | ||
| 39179682 | 奥锐特药业股份有限公司关于部分限制性股票回购注销实施公告 | 2025-12-30 | Chinese | ||
| 39179673 | 奥锐特药业股份有限公司股东减持股份结果公告 | 2025-12-24 | Chinese | ||
| 39179671 | 奥锐特药业股份有限公司关于通过药品GMP符合性检查的公告 | 2025-12-18 | Chinese | ||
| 39179662 | 奥锐特药业股份有限公司关于以集中竞价交易方式回购公司股份的进展公告 | 2025-12-01 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Aurisco Pharmaceutical Co.,Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/57980/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=57980 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=57980 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=57980 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 57980}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Aurisco Pharmaceutical Co.,Ltd. (id: 57980)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.